ProCE Banner Activity

Pharmacist Role: Monitoring Responses to CP-CML Therapy

Slideset

Access these slides to learn what oncology pharmacists need to know to properly incorporate BCR::ABL1 molecular and mutational monitoring into the management of patients with CP-CML.

Released: April 24, 2025

Expiration: October 23, 2025

Share

Provided by

Provided by ProCE LLC. in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Partners

Clinical Care Options, LLC

ProCE Banner